The article focuses on a statement by physician Caroline C. W. Klaver that direct-to-consumer genetic tests for age-related macular degeneration (AMD) that are available via the Internet are not reliable in providing risk assessment, and mentions reasons for inaccuracy, one of which is the testing of a limited set of genetic variants.